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ABSTRACT The intracellular signaling molecule cyclic diguanylate (c-di-GMP) regu-
lates many processes in bacteria, with a central role in controlling the switch be-
tween motile and nonmotile lifestyles. Recent work has shown that in Clostridium
difficile (also called Clostridioides difficile), c-di-GMP regulates swimming and surface
motility, biofilm formation, toxin production, and intestinal colonization. In this
study, we determined the transcriptional regulon of c-di-GMP in C. difficile, employ-
ing overexpression of a diguanylate cyclase gene to artificially manipulate intracellu-
lar c-di-GMP. Consistent with prior work, c-di-GMP regulated the expression of genes
involved in swimming and surface motility. c-di-GMP also affected the expression of
multiple genes encoding cell envelope proteins, several of which affected biofilm
formation in vitro. A substantial proportion of the c-di-GMP regulon appears to be
controlled either directly or indirectly via riboswitches. We confirmed the functional-
ity of 11 c-di-GMP riboswitches, demonstrating their effects on downstream gene
expression independent of the upstream promoters. The class I riboswitches uni-
formly functioned as “off” switches in response to c-di-GMP, while class II ribo-
switches acted as “on” switches. Transcriptional analyses of genes 3= of c-di-GMP ri-
boswitches over a broad range of c-di-GMP levels showed that relatively modest
changes in c-di-GMP levels are capable of altering gene transcription, with concomi-
tant effects on microbial behavior. This work expands the known c-di-GMP signaling
network in C. difficile and emphasizes the role of the riboswitches in controlling
known and putative virulence factors in C. difficile.
IMPORTANCE In Clostridium difficile, the signaling molecule c-di-GMP regulates mul-
tiple processes affecting its ability to cause disease, including swimming and surface
motility, biofilm formation, toxin production, and intestinal colonization. In this
study, we used RNA-seq to define the transcriptional regulon of c-di-GMP in C. diffi-
cile. Many new targets of c-di-GMP regulation were identified, including multiple pu-
tative colonization factors. Transcriptional analyses revealed a prominent role for ri-
boswitches in c-di-GMP signaling. Only a subset of the 16 previously predicted c-di-
GMP riboswitches were functional in vivo and displayed potential variability in their
response kinetics to c-di-GMP. This work underscores the importance of studying
c-di-GMP riboswitches in a relevant biological context and highlights the role of the
riboswitches in controlling gene expression in C. difficile.
KEYWORDS Clostridium difficile, biofilms, c-di-GMP, cyclic diguanylate, flagellar
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Cyclic diguanylate (c-di-GMP) is nearly ubiquitous in bacteria and well known toregulate a variety of processes, particularly the switch between motile and sessile
states (1–4). In some pathogens, c-di-GMP also controls virulence factor production
(5–10). In response to largely undefined extracellular cues, the intracellular c-di-GMP
concentration is modulated through the opposing activities of diguanylate cyclases
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(DGCs) and phosphodiesterases (PDEs). These enzymes may be controlled at the
transcriptional and posttranslational level to adjust intracellular c-di-GMP. Many bac-
teria encode multiple DGCs and PDEs leading to complex c-di-GMP signaling networks.
Changes in intracellular c-di-GMP are sensed by specific receptors that respond with
changes to their activity or function. Multiple protein receptors of c-di-GMP receptors
have been identified, including PilZ domains, diguanylate cyclases containing I-sites,
GIL proteins, MshEN domains, and the Cle subfamily of CheY proteins (11–16). c-di-GMP
can also bind to certain transcription factors and alter their activity (17–19). In addition
to these protein receptors, c-di-GMP can bind to two distinct RNA structures, the class
I (GEMM) and class II c-di-GMP riboswitches, to carry out its regulatory function (20, 21).
Riboswitches are found in the 5= untranslated region (UTR) of some transcripts. Binding
of a ligand to the riboswitch alters the secondary structure of the RNA to promote or
inhibit transcript termination, mRNA stability, or translation initiation (22, 23). Charac-
terization of gene regulation by c-di-GMP riboswitches has largely relied on experi-
ments using purified c-di-GMP and transcripts generated through in vitro transcription
or using heterologous hosts (20, 25). However, little work has been done to directly test
the role of c-di-GMP riboswitches in their native genetic contexts in vivo.
Clostridium difficile is an obligate anaerobe capable of causing intestinal disease
ranging from mild diarrhea to potentially fatal pseudomembranous colitis and toxic
megacolon. Recent work suggests that c-di-GMP plays a key role in controlling the
production of surface structures involved in host colonization by C. difficile. For exam-
ple, C. difficile produces peritrichous flagella that are involved in intestinal colonization,
and the flagellum itself may serve as an adhesin (26–28). The expression of flagellar
genes, flagellum biosynthesis, and motility are negatively regulated by c-di-GMP (29).
C. difficile also produces type IV pili (TFP) that participate in autoaggregation, biofilm
formation, adherence to epithelial cells, and persistence of C. difficile in the mammalian
intestine (30–32). The production of TFP is positively regulated by c-di-GMP, also at the
level of transcriptional regulation (30). In addition, two sortase-dependent surface
proteins, encoded by CD630_28310 and CD630_32460, are positively regulated by
c-di-GMP (21, 33), although the contribution of these proteins to adherence and host
colonization has not been reported. Interestingly, the ZmpI zinc-dependent metallo-
protease, which cleaves the CD630_28310 and CD630_32460 proteins, is negatively
regulated by c-di-GMP (33).
C. difficile strain 630 encodes 37 proteins with putative or demonstrated DGC or PDE
activity (25, 29, 34). Additionally, C. difficile 630 encodes 16 predicted class I and class
II c-di-GMP sensing riboswitches, more than any sequenced bacterial genome outside
a few deltaproteobacteria, suggesting an important role for c-di-GMP signaling through
riboswitches in this organism (2, 20, 21). The presence of truncated RNAs corresponding
to 7 of the c-di-GMP riboswitches has been confirmed by Northern blotting (35).
Notably, each of the loci described above, CD630_28310, CD630_32460, zmpI, and pilA1
(TFP major pilin gene), and the flgB operon (flagellar genes) are preceded by a c-di-GMP
riboswitch (20, 21). Regulation of pilA1 expression has been demonstrated to occur
through the Cdi-2-4 riboswitch in the 5= UTR of the transcript (30–32). In the presence
of c-di-GMP, the Cdi-2-4 riboswitch assumes a secondary structure that allows tran-
scription read-through and expression of the downstream TFP genes, consistent with
the observed positive regulation of pilus gene expression and TFP production by
c-di-GMP in vivo (30, 31). Conversely, c-di-GMP binding to the Cdi-1-3 riboswitch in the
5= UTR of the flgB operon mRNA causes transcript termination, leading to a decrease in
the transcription of flgB and other genes in the early-stage flagellar operon (20, 29, 35).
The processes regulated by c-di-GMP in C. difficile identified to date have been
identified based on the presence of putative c-di-GMP riboswitches upstream of the
relevant loci, and studies have specifically focused on those loci affecting measurable
phenotypes. Yet evidence suggests that additional c-di-GMP-regulated factors remain
to be identified. For example, the adherence behaviors that occur in C. difficile in
response to elevated c-di-GMP can be attributed only in part to regulation of TFP and
flagellar biosynthesis (29–32). Inactivation of TFP genes reduces, but does not eliminate,
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biofilm formation in response to c-di-GMP in C. difficile 630Δerm (31). Similarly, c-di-
GMP-mediated increases in adherence to epithelial cells in vitro can be only partly
explained by inhibition of flagellum biosynthesis (27, 32). The broader role of c-di-GMP
signaling in C. difficile has not been determined.
In this study, we used RNA-seq to identify additional factors regulated by c-di-GMP
in C. difficile. The analysis took advantage of a previously developed strategy for
artificial manipulation of c-di-GMP in C. difficile, which allowed us to compare the
transcriptomes of C. difficile strain 630Δerm with elevated intracellular c-di-GMP con-
centrations and basal c-di-GMP levels. Transcriptional analyses demonstrated a prom-
inent role for riboswitches in the c-di-GMP signaling system of C. difficile and allowed
us to examine the in vivo functionality of the 16 predicted c-di-GMP riboswitches in this
organism. Eleven showed an ability to regulate gene expression in response to c-di-
GMP, with class I riboswitches functioning as “off” switches and class II riboswitches
functioning as “on” switches. Differences in responsiveness to changes in c-di-GMP
were observed, suggesting that individual riboswitches of the same class display
distinct thresholds of activation. This work underscores the importance of examining
c-di-GMP riboswitch function in a relevant biological context and highlights the role of
the riboswitches in controlling known and putative virulence factors in C. difficile.
RESULTS
c-di-GMP controls the transcription of a large number of genes in C. difficile. To
identify the genes regulated by c-di-GMP, we used RNA-seq to compare the transcrip-
tomes of C. difficile 630Δerm with wild-type or elevated c-di-GMP levels. C. difficile with
pMC-Pcpr (vector control) served as the wild type, which we previously determined to
contain low levels of c-di-GMP (near the limit of detection by UPLC-MS) (29). To increase
intracellular c-di-GMP, the diguanylate cyclase gene dccA was expressed from a plas-
mid, pDccA, under the control of the nisin-inducible cpr promoter (29). C. difficile
630Δerm bearing pDccA or vector control was grown to mid-exponential phase with
1 g/ml nisin, and RNA was processed for sequencing. Genes were considered to be
regulated using the following criteria: changes in reads mapped per kilobase per
million reads (RPKM) of 2-fold between the two conditions and P  0.05 by Bonfer-
roni’s correction. A complete list of the differentially expressed genes is found in
Table S3 in the supplemental material. These genes were grouped according to the
predicted Riley functional class of their encoded proteins (Fig. 1) (36, 37).
A total of 166 genes met the criteria, with 124 genes negatively regulated and 42
positively regulated by c-di-GMP (Fig. 1). The largest class of genes regulated by
c-di-GMP were genes involved in chemotaxis and flagellar motility (37 total genes).
FIG 1 C. difficile genes regulated by c-di-GMP grouped by Riley classification of predicted gene products.
Genes were included if the fold change in expression (differences in RPKM) was greater than 2-fold and
P value was 0.05 after Bonferroni’s correction for multiple comparisons.
Riboswitch-Mediated c-di-GMP Signaling in C. difficile
September/October 2018 Volume 3 Issue 5 e00423-18 msphere.asm.org 3
These genes account for nearly 25% of the c-di-GMP-regulated genes identified.
Consistent with previous work showing that c-di-GMP negatively regulates flagellar
motility, all these genes showed decreased expression in response to increased c-di-
GMP (pDccA strain) (Fig. 1). The next largest set of c-di-GMP-regulated genes are known
or predicted to encode proteins that localize to the cell envelope. Among this set are
genes involved in biosynthesis of TFP, which showed increased expression in response
to c-di-GMP, consistent with previous studies (30, 32). Three genes encoding putative
surface proteins, CD630_27970, CD630_28310, and CD630_32460, were also in this
category, and all three genes are preceded by predicted c-di-GMP riboswitches. The
third major class of c-di-GMP-regulated genes encode proteins predicted to be involved
in transport/binding. Of these, seven are predicted PTS system proteins that are likely
involved in importing sugars or sugar alcohols, and six are predicted components of
ABC-type transporters. Across the remaining classes, several of the remaining genes are
predicted to encode phage proteins, proteins involved in the transfer of mobile genetic
elements, and proteins involved in iron regulation (e.g., FeoB1) or oxidative stress (e.g.,
Rbr1 and TrxA1).
Increased intracellular c-di-GMP moderately affects transcription of c-di-GMP
metabolism genes. Because ectopic expression of dccA greatly increases intracellular
c-di-GMP, we considered that the C. difficile c-di-GMP signaling system might compen-
sate by altering other c-di-GMP enzymes to buffer against altered c-di-GMP. To address
this possibility, we examined the RNA-seq data for genes encoding the GGDEF and/or
EAL domains that synthesize and degrade c-di-GMP, respectively. As expected, tran-
scription of dccA was significantly elevated (8.6-fold) in C. difficile pDccA (Fig. S1). One
other locus, CD630_07570 encoding a GGDEF-EAL domain phosphodiesterase (25, 34),
showed a significant (5.1-fold) decrease in transcription, which suggests a further
increase in intracellular c-di-GMP. Several other c-di-GMP metabolism genes showed
modest changes in expression but did not meet the defined statistical cutoff. As a
group, those containing GGDEF domains, most of which are confirmed DGCs (25, 34),
showed no particular upward or downward trend in transcription in C. difficile pDccA.
However, those with tandem GGDEF-EAL domains, most of which function as PDEs (25,
34), showed a trend toward increased transcription. When analyzed individually by t
test, many of the genes showed statistically significant changes in expression. These
results suggest that C. difficile may cumulatively buffer against increased c-di-GMP by
moderately increasing the expression of multiple phosphodiesterase genes. It also
remains possible that existing DGC and PDE enzymes are regulated posttranslationally
in response to elevated c-di-GMP.
Genes predicted to be controlled by class I and class II riboswitches are well
represented among c-di-GMP-regulated genes. A total of 16 c-di-GMP riboswitches
are predicted in C. difficile 630: twelve class I (GEMM) riboswitches and four class II
riboswitches (20, 21). Of the 12 class I riboswitches, transcripts corresponding to the
genes downstream of 7 were significantly altered (Table 1). Transcript abundances for
six of these loci were significantly lower in C. difficile pDccA than the vector control,
with fold changes ranging from 4.66 to 62.61. These results suggest that these class
I riboswitches generally function as “off” switches in response to c-di-GMP. The nega-
tively regulated loci encode flagella (Cdi-1-3), a calcium binding putative adhesin
(Cdi-1-2), and the zinc-dependent metalloprotease ZmpI (Cdi-1-12) (38). The remaining
three encode hypothetical proteins (Cdi-1-8, Cdi-1-9, and Cdi-1-11). In contrast, the
expression of CD630_19900, the gene downstream of Cdi-1-1, was increased more than
30-fold, and this gene is the sole class I riboswitch-regulated gene positively regulated
by c-di-GMP.
For the remaining five class I riboswitches (Cdi-1-4, Cdi-1-5, Cdi-1-6, Cdi-1-7, and
Cdi-1-10), no coding sequence was detectable downstream of the riboswitch based on
either the genome annotation or analysis of the reads in the regions (Table 1 and
Fig. S2). Transcript reads corresponding to the riboswitch sequences themselves were
detected (Fig. S2), albeit at very low levels. Transcripts for annotated genes overlapping
riboswitches Cdi-1-6 and Cdi-1-10 significantly differed between C. difficile pDccA and
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the control. These results suggest these mRNAs are nonfunctional riboswitches or have
functions other than gene regulation in cis.
The class I c-di-GMP riboswitches are generally highly conserved in C. difficile, with
Cdi-1-1, Cdi-1-6, Cdi-1-8, Cdi-1-9, Cdi-1-10, Cdi-1-11, and Cdi-1-12 present in all 54
complete genomes available on NCBI (Fig. S3). Cdi-1-2 and Cdi-1-3 are absent in a
subset of strains that also lack the downstream CD630_27970 and flgB genes, respec-
tively. Notably, the nonfunctional Cdi-1-4 and Cdi-1-5 and their downstream regions
appear to be duplications in C. difficile 630 and 630Δerm, and they are absent from
most available C. difficile genomes (Fig. S3). Cdi-1-4 and Cdi-1-5 are most similar to
Cdi-1-7, which may explain their common lack of function.
In contrast to the majority of class I riboswitch loci, the transcript abundances for the
four genes downstream of class II riboswitches were significantly higher (4.29- to
42.51-fold) in C. difficile pDccA than in the vector control, indicating that class II
riboswitches are uniformly “on” switches in C. difficile. Three of these riboswitches
positively regulate known or putative adhesins in response to c-di-GMP. Cdi-2-1
regulates CD630_32460, which encodes a protein predicted to localize to the bacterial
surface. Cdi-2-3 regulates CD630_28310, a putative adhesin with a predicted collagen
binding domain (33). Notably, the products of these genes have been shown to be
sortase-dependent proteins cleaved by the ZmpI metalloprotease that is negatively
regulated by c-di-GMP through Cdi-1-12 (33, 38). Cdi-2-4 controls expression of genes
encoding TFP, which are involved in adherence to epithelial cells and intestinal
colonization (32). Cdi-2-3 and Cdi-2-4 and their downstream genes are highly con-
served in C. difficile genomes (Fig. S3). In contrast, Cdi-2-1 and the downstream
CD630_32460 are present in approximately 2/3 of the genomes. Interestingly, though
CD630_32670 is highly conserved in all of the available genomes, about 1/3 lack the
upstream Cdi-2-2 riboswitch, suggesting alternative modes of regulation in some
strains.
To validate the RNA-seq results, we performed qRT-PCR using RNA isolated from C.
difficile with vector, pDccA, or pDccAmut grown in the presence or absence of 1 g/ml
nisin. The pDccAmut vector encodes a catalytically inactive form of DccA and allows us
to attribute regulation specifically to increased c-di-GMP and not another potential
function of the DccA protein (29). Four out of the seven genes adjacent to class I
riboswitches showed decreased transcript levels in C. difficile pDccA (Table 2). Expres-





(pDccA/vector)c Downstream gene Chromosome regionb
Fold change gene
(pDccA/vector)d
Cdi-1-1 () 2296134 13.44f CD630_19900 () 2295867...2296352 31.90
Cdi-1-2 () 3266578 15.63f CD630_27970 () 3260792...3266755 7.15
Cdi-1-3 () 308778 2.74 CD630_02450 (flgB) () 309272...309589 15.06
Cdi-1-4 () 3379981 1.02 NDe
Cdi-1-5 () 1142269 1.03 ND
Cdi-1-6 () 2285923 6.41 ND
Cdi-1-7 () 2907226 1.19 ND
Cdi-1-8 () 2297492 9.25 CD630_19903 () 2297643...2297819 7.78
Cdi-1-9 () 2671809 4.81 CD630_23090 () 2671951...2672127 4.66
Cdi-1-10 () 1653520 2.07 ND
Cdi-1-11 () 3936240 8.49 CD630_33682 () 3936389...3936565 8.90
Cdi-1-12 () 3303074 31.30 CD630_28300 (zmpI) () 3302613...3303275 62.61
Cdi-2-1 () 3801063 4.48 CD630_32460 () 3798299...3800482 4.29
Cdi-2-2 () 3826609 2.34 CD630_32670 () 3825352...3826029 18.78
Cdi-2-3 () 3306681 1.10 CD630_28310 () 3303646...3306564 42.51
Cdi-2-4 () 4105796 4.10 CD630_35130 (pilA1) () 4105120...4105635 11.74
aRiboswitch naming and start sites based on predictions by Sudarsan et al. (20) and Lee et al. (21).
b(/) indicates sense versus antisense strand.
cFold change for the riboswitch region only.
dFold change for the gene 3= of the riboswitch.
eND, no downstream genes or transcripts detected.
fBoldface and italic indicate significantly increased and decreased abundance relative to the vector control condition, respectively.
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sion of all four of the genes 3= of the class II c-di-GMP riboswitches was significantly
increased in C. difficile with pDccA compared to the vector and pDccAmut controls
(Table 3). The average transcript levels for the other three genes was decreased in
agreement with the RNA-seq data, but the differences did not meet statistical signifi-
cance.
Expression of genes downstream of predicted c-di-GMP riboswitches is altered
in response to small changes in c-di-GMP. The RNA-seq analysis was done following
induction of dccA expression with 1 g/ml nisin to ensure a robust increase in c-di-GMP
and to maximize identification of regulated genes. However, previous studies found
that this induction level increased intracellular c-di-GMP up to 2,000-fold, which is likely
not a biologically meaningful change (29). We thus sought to determine the effect of
more subtle changes in c-di-GMP on C. difficile gene expression. In addition, the
presence of a large set of genes regulated (both positively and negatively) by
c-di-GMP riboswitches provides the opportunity to examine the differences in
responsiveness of this class of c-di-GMP receptor to changes in intracellular c-di-
GMP. For example, differences between riboswitches of the same type may result in
changes to ligand affinity, resulting in responses to different threshold concentra-
tions of c-di-GMP (20, 39).
To evaluate the responsiveness of the riboswitches to c-di-GMP, we measured the
transcript abundance of the gene immediately 3= of each riboswitch in C. difficile with
a range of intracellular c-di-GMP concentrations. To achieve a range of intracellular
c-di-GMP concentrations, C. difficile pDccA was grown with nisin inducer in concentra-
tions ranging from 0 to 1 g/ml. This range of nisin concentrations resulted in a
dose-dependent decrease in swimming motility of the C. difficile pDccA strain, with
0.1 g/ml resulting in a downward trend in motility and 0.25 g/ml significantly
inhibiting motility (Fig. S4). As controls, C. difficile with vector or pDccAmut was grown
with 0 or 1 g/ml nisin. The cultures were divided, with one portion used for nucleotide
extraction and measurement of intracellular c-di-GMP concentration by UPLC-MS, and
the other portion used for RNA extraction and evaluation of transcript abundance by
qRT-PCR. The control strains contained low intracellular c-di-GMP concentrations
(131 nM  268 nM) regardless of nisin addition, consistent with previously reported
data for C. difficile (29). Induction of dccA with increasing levels of nisin led to a
TABLE 2 Fold changes in transcripts for genes controlled by class I (GEMM) riboswitches as determined by qRT-PCR
Location and
growthc 19900,a Cdi-1-1 27970, Cdi-1-2
02450 (flgB),
Cdi-1-3 19903, Cdi-1-8 23090, Cdi-1-9 33682, Cdi-1-11
28300 (zmpI),
Cdi-1-12
Vector  1 1 1 1 1 1 1
Vector  1.09 1.46 1.21 0.81 0.85 0.61 0.85
pDccAmut  1.28 2.02 1.50 1.61 1.48 1.27 1.44
pDccAmut  1.27 1.82 1.57 2.04 2.12 1.25 0.90
pDccA  3.25b 0.70 1.12 1.75 1.58 1.18 1.72
pDccA  149.50 0.24 0.18 0.59 0.31 0.34 0.15
aLocus tag from C. difficile 630 genome sequence (GenBank accession no. AM180355.1) and upstream riboswitch.
bBold numbers indicate values significantly different (P  0.05) from C. difficile with vector grown without nisin, by 2-way ANOVA.
c/ indicates cultures grown with or without 1 g/ml nisin, respectively.
TABLE 3 Fold changes in transcripts for genes controlled by class II c-di-GMP riboswitches as determined by qRT-PCR
Location and growthc 32670,a Cdi-2-1 32460, Cdi-2-2 28310, Cdi-2-3 35130 (pilA1), Cdi-2-4
Vector  1 1 1 1
Vector  0.87 0.75 0.99 0.82
pDccAmut  1.14 1.07 1.27 1.12
pDccAmut  1.16 0.76 0.88 0.60
pDccA  1.25 1.88 2.43 2.22
pDccA  4.76b 17.35 40.86 18.44
aLocus tag from C. difficile 630 genome sequence (GenBank accession no. AM180355.1) and upstream riboswitch.
bBold numbers indicate values significantly different (P  0.05) from C. difficile with vector grown without nisin, by 2-way ANOVA.
c/ indicates cultures grown with or without 1 g/ml nisin.
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dose-dependent increase in c-di-GMP, yielding a near-linear 156-fold range from
630 nM with no nisin to 99 M at the highest nisin concentration (Fig. 2 and 3 and
Fig. S5). The corresponding effects of c-di-GMP on transcript abundance for the
downstream gene were expressed as the fold change compared to vector control
FIG 2 Regulation of genes downstream of class I (GEMM) riboswitches by c-di-GMP. C. difficile with vector or pDccA
was grown with a range of nisin concentrations (g/ml). Cultures were divided for quantification of intracellular
c-di-GMP concentration by LC-MS (red) or measurement of transcript abundance for the downstream open reading
frame by qRT-PCR (blue). Lines and error bars represent the geometric mean and geometric standard deviation. Not
shown are those for which no downstream open reading frame or transcript was identified.
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grown without nisin. We note that the nonnormalized abundances are affected by the
strength of the respective promoters and vary greatly between the loci (Fig. S6).
For most of the genes, transcript abundance was significantly different between C.
difficile pDccA grown with 0.1 g/ml nisin and C. difficile with vector grown without
nisin (Fig. 2 and 3). These conditions correspond to a 19-fold difference in intracellular
c-di-GMP, as well as a detectable decrease in swimming motility (see Fig. S4 and S5).
Increasing nisin concentrations above 0.1 g/ml generally resulted in modest addi-
tional effects on the expression of these genes, though there were differences in the
range of responses to c-di-GMP. For example, the abundances of the CD630_27970,
CD630_19903, CD630_23090, and CD630_33682 transcripts decreased between 0, 0.01,
and 0.1 g/ml nisin (632 nM, 2.54 M, and 13.67 M c-di-GMP, respectively) and then
remained constant up to 1 g/ml nisin (99 M c-di-GMP) (Fig. 2). In contrast, the
transcript abundances of flgB and zmpI continued to decrease with increasing c-di-GMP.
One possible explanation for these differences is that the baseline gene expression
varies, affecting the number of target RNA molecules available for saturation of binding
by c-di-GMP. However, despite dissimilar expression kinetics in response to c-di-GMP,
CD630_27970, flgB, and zmpI showed comparable baseline transcript levels (Fig. S6).
These differences reflect potential variability in the responsiveness of class I ribo-
switches to c-di-GMP.
Regulation through class II c-di-GMP riboswitches similarly shows the greatest response
between 632 nM (baseline), 2.54 M, and 13.67 M c-di-GMP (Fig. 3). CD640_32670,
CD630_28310, and pilA1 increased 4.4-, 10.1-, and 3.9-fold in this range and reached 11.7-,
18.6-, and 10.8- fold increases in C. difficile with 99 M c-di-GMP, respectively.
CD630_32460 transcript abundance increased more gradually, reaching a maximum
4.9-fold increase in C. difficile with 99 M c-di-GMP. Taken together, these results
indicate that gene regulation via c-di-GMP riboswitches occurs in response to small and
likely physiologically relevant changes in c-di-GMP in vivo.
Regulation of CD630_19900 expression by c-di-GMP occurs at multiple levels.
Based on RNA-seq and qRT-PCR analyses, class I c-di-GMP riboswitches in C. difficile
FIG 3 Genes 3= of class II c-di-GMP riboswitches are positively regulated by c-di-GMP. C. difficile with vector or
pDccA was grown with a range of nisin concentrations (g/ml). Cultures were split for quantification of intracellular
c-di-GMP concentration by LC-MS (red) or measurement of transcript abundance for the downstream open reading
frame by qRT-PCR (blue). Lines and error bars represent the geometric mean and geometric standard deviation.
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appeared to function as “off” switches with the exception of Cdi-1-1, for which
expression of the downstream CD630_19900 gene increased in response to c-di-GMP.
However, recent work on the Vc2 c-di-GMP riboswitch in Vibrio cholerae demonstrated
that c-di-GMP can impact expression of a gene at multiple levels (40). In the case of Vc2,
positive regulation by c-di-GMP via the promoter could override inhibition of expres-
sion through Vc2, leading to an observed increase in gene expression in response to
c-di-GMP. To address the possibility that c-di-GMP also regulates transcription initiation
of CD630_19900, and possibly other genes, we generated transcriptional fusions of the
alkaline phosphatase (AP) reporter gene phoZ to the regions encompassing each of the
promoters but excluding the riboswitches. The fragments consisted of 200 bp
encompassing the promoter (location estimated based on RNA-seq read mapping) and
at most 10 bases of the 5= end of the riboswitch sequences such that no functional
riboswitch is present, allowing us to specifically determine the extent of c-di-GMP
regulation via the promoters. These fusions were integrated into the C. difficile 630Δerm
chromosome, and then pDccA or vector was introduced. The strains were grown with
a range of nisin concentrations to induce dccA expression and c-di-GMP production,
and then AP activity was assayed as previously described (41).
For the CD630_19900 promoter fusion, AP activity increased in response to nisin in
a dose-dependent manner, up to a 13-fold increase in activity between the lowest and
highest c-di-GMP levels tested (Fig. 4A). These results indicate that transcription initi-
ation is positively regulated by c-di-GMP. c-di-GMP may still inhibit transcription
read-through via the riboswitch, but the increased expression from the promoter is
dominant under these conditions. Fusions to promoter regions for the remaining loci
showed no change or up to a 2-fold change in expression at the highest concentration
of c-di-GMP (Fig. 4B), suggesting that c-di-GMP does not substantially affect their
transcription initiation.
c-di-GMP broadly regulates the composition of the C. difficile cell surface to
influence surface interactions. The RNA-seq analysis supported prior studies showing
that c-di-GMP negatively regulates the production of flagella by inhibiting flagellar
gene expression, and positively regulates type IV pilus biosynthesis by promoting
TFP gene expression. In addition, c-di-GMP positively regulates CD630_28310 and
CD630_32460, which encode sortase-dependent surface proteins, and inhibits expres-
sion of the ZmpI zinc-dependent metalloprotease that cleaves them (21, 33). Transcrip-
tional analysis identified additional c-di-GMP-regulated candidate surface proteins
involved in C. difficile adherence: CD630_19870, CD630_27950, CD630_27960, and
CD630_27970. While the last three are adjacent on the chromosome, they are diver-
gently transcribed and do not compose an operon. The fold changes in transcript levels
for these six genes under elevated c-di-GMP conditions, based on the RNA-seq
FIG 4 Alkaline phosphatase reporter assays of riboswitch-adjacent gene promoters. C. difficile 630Δerm bearing
promoter-phoZ reporter fusions and either vector or pDccA was grown to mid-exponential phase with the
indicated concentration of nisin (g/ml). (A) Reporter activity for C. difficile with the Cdi-1-1 (CD630_19900)
promoter fusion, grown with a range of nisin concentrations. (B) Reporter activity for C. difficile with fusions to the
promoter regions upstream of the indicated riboswitches (but lacking the riboswitches themselves), grown with or
without 1 g/ml nisin (black bars and white bars, respectively). The means and standard deviations of 3 biological
replicates are shown. **, P  0.01; ***, P  0.001; and ****, P  0.0001, using one-way ANOVA and Dunnett’s
posttest, compared to the induced vector control for the respective reporter fusion.
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analysis, are listed in Table 4. We speculated that one or more of these proteins
plays a role in biofilm formation, a process that is promoted by c-di-GMP in C.
difficile (31, 35). To test this, genes encoding the individual cell envelope proteins
were expressed ectopically in C. difficile from an ATc-inducible promoter (Ptet)
during growth in static culture for 24 h to allow biofilm development (31). Four of
the six genes (CD630_27950, CD630_27960, CD630_27970, and CD630_32460) signif-
icantly increased biofilm formation compared to the vector control (Fig. 5). The
remaining two genes (CD630_19870 and CD630_28310) also increased biofilm forma-
tion somewhat, but the results did not achieve statistical significance.
DISCUSSION
In this work, we set out to define the transcriptional regulon of c-di-GMP in the
human pathogen C. difficile. We found that c-di-GMP regulates a total of 166 genes
under the growth conditions tested. While many of these genes were previously
identified members of the c-di-GMP regulon in C. difficile (29, 30, 33), numerous
additional c-di-GMP-regulated cellular processes were identified. Known and putative
colonization factors were prominent in the regulon, consistent with a role for c-di-GMP
in adherent behaviors of C. difficile (29–33).
Genes directly regulated via c-di-GMP riboswitches were highly represented, includ-
ing 29 flagellar genes contained in the 23 kb flgB operon directly regulated by Cdi-1-3
and the TFP genes directly regulated by Cdi-2-4. For many of the remaining genes, the
mechanism of regulation by c-di-GMP is unclear. The only predicted transcriptional
regulators identified were SigD and two putative response regulators containing DNA
binding domains (CD630_32650 and CD630_32670). These three regulators are en-
TABLE 4 Putative cell envelope proteins whose expression is regulated by c-di-GMP
Locus Fold changea (pDccA/vector) Predicted function Riboswitch upstream?
CD630_19870 4.32 Cell wall protein 28 No
CD630_27950 2.90 Cell wall protein 11 No
CD630_27960 4.06 Cell wall protein 10 No
CD630_27970 7.15 Calcium-binding adhesion protein Yes
CD630_28310 42.51 Putative adhesin Yes
CD630_32460 4.29 Surface protein Yes
aBoldface and italic indicate significantly increased and decreased abundance relative to the vector control, respectively, as determined using RNA-seq.
FIG 5 Expression of genes encoding cell envelope proteins promotes biofilm formation. Genes encoding
putative cell envelope proteins were expressed under the control of an ATc-inducible promoter in C.
difficile 630Δerm. The strains were grown in 24-well plates in buffered BHIS containing 1% glucose and
20 ng/ml ATc to induce gene expression during biofilm development. Biofilm formation was assayed by
crystal violet after 24-h incubation. Values are normalized to the induced vector control. Symbols indicate
values from independent biological replicates, and bars indicate the means and standard deviations for
six independent replicates. *, P  0.05; **, P  0.01; and ****, P  0.0001, by 1-way ANOVA and Dunnett’s
posttest, compared to the vector control.
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coded in operons directly controlled by c-di-GMP riboswitches and could relay changes
in intracellular c-di-GMP to modulate expression of other loci. For example, SigD
coordinates the indirect activation of flagellar genes carried outside the flgB operon, as
well as a number of other genes involved in metabolism, membrane transport, and
toxin biosynthesis (8, 29, 42). The partial overlap between the c-di-GMP regulon and the
previously reported SigD regulon indicates the subset of genes controlled by the SigD
sigma factor (42). The response regulators encoded by CD630_32650 and CD630_32670
likely mediate c-di-GMP regulation for additional genes. In addition, although no
protein receptors of c-di-GMP have been identified in C. difficile to date, it is possible
that c-di-GMP posttranslationally regulates the function of proteins that in turn mod-
ulate gene expression, as described in other species (18, 19, 43).
Of the 16 predicted c-di-GMP riboswitches in C. difficile, 11 are carried near genes on
the same coding strand, positioning them to regulate the expression of these down-
stream genes. Consistent with this, expression of these 11 genes was altered by
increasing the c-di-GMP concentration in vivo in a dose-dependent manner, with a
19-fold increase in c-di-GMP resulting in a significant change in gene expression. The
normal dynamic range of c-di-GMP in C. difficile in response to extracellular stimuli is
unknown, so it is unclear whether the 19-fold increase reflects a biologically meaningful
change. Motility assays showed that a comparable level of dccA induction results in
detectable changes in C. difficile swimming in vitro. These results indicate that even
small increases in c-di-GMP are capable of altering gene expression, with consequent
effects on C. difficile physiology and behavior. One limitation of our study is that it was
not possible to determine quantitatively the effects of reducing c-di-GMP on gene
expression, as basal c-di-GMP levels present in the control strain were already near the
limit of detection. In addition, the measurements described averaged c-di-GMP con-
centrations and transcript levels across the population. Prior work in C. difficile and
other species suggests heterogeneity in c-di-GMP levels, and concomitantly in gene
expression, among individual bacteria (44–47). Thus, measurements of c-di-GMP and
mRNA in bulk populations may under- or overestimate the responses of single cells.
Initial transcriptional analyses indicated that class II riboswitches are uniformly “on”
switches, while all but one class I riboswitch are “off” switches in response to c-di-GMP
in C. difficile. However, there are multiple examples of ligands also affecting the activity
of the promoter upstream of their cognate riboswitch (39, 40, 48, 49). For example, in
vivo studies of class I c-di-GMP riboswitches in Vibrio cholerae, Vc1 and Vc2, showed that
c-di-GMP regulates the expression the downstream genes gbpA and tfoY at two levels:
by controlling transcription initiation via the upstream promoters and via the ribo-
switches (39, 40). Moreover, the two control mechanisms acted in opposing directions
(39, 49). Using reporter fusions to the regions upstream of the functional c-di-GMP
riboswitches in C. difficile, we found that c-di-GMP controls expression of CD630_19900
via the promoter. These results may explain the observation that CD630_19900 is
overall positively regulated by c-di-GMP; despite being preceded by a class I riboswitch,
which presumably functions as an “off” switch, regulation via the promoter supersedes
riboswitch control under the conditions tested. Thus, while in vitro transcription can be
used to measure interactions between c-di-GMP and mRNA, these interactions need to
be placed in the appropriate biological context before making conclusions about
c-di-GMP regulation in vivo.
Of six genes encoding cell wall-localized proteins, four significantly increased in vitro
biofilm formation when overexpressed. Despite negative regulation by c-di-GMP,
CD630_27960 and CD960_27970 increased biofilm formation when overexpressed. We
speculate that overexpression caused unexpected changes to the composition of the
cell surface or overall bacterial physiology, resulting in more adherent bacteria inde-
pendent of the individual gene expressed. Ongoing studies examining mutants in these
genes, individually and in combination, will determine the roles of these loci in the
surface behaviors of C. difficile. Several studies have described C. difficile biofilm
development in vitro (50–54), and a few microbial factors that contribute to this process
have been reported, including cell surface proteins, their regulators, and more (31, 35,
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55–62). Some of the factors involved in biofilm formation include surface proteins
regulated by c-di-GMP, including TFP, flagellin, CD630_28310, and CD630_32460 (31,
55, 56, 63). The contribution of biofilm formation to C. difficile disease remains largely
speculative. In vitro biofilms are reservoirs for spores, accumulate toxins, and show
increased antibiotic tolerance, suggesting that biofilms may aid in persistent coloniza-
tion and disease recurrence (51, 56, 64). Recent work using animal models supports that
C. difficile is present in microbial communities with biofilm-like characteristics (65, 66).
Future studies examining factors required for biofilm development, including those
regulated by c-di-GMP, could be used to determine the importance of biofilms to C.
difficile disease.
In summary, this work expands the known c-di-GMP signaling network, demon-
strates the functionality of c-di-GMP riboswitches in this organism, and highlights the
role of the riboswitches in controlling known and putative virulence factors in C.
difficile.
MATERIALS AND METHODS
Bacterial growth conditions. C. difficile cultures were grown at 37°C in an atmosphere of 5% CO2,
5% H2, and 90% N2 using a Coy anaerobic chamber. Overnight cultures of C. difficile were grown in 2 to
5 ml of TY medium (30 g/liter Bacto tryptone, 20 g/liter yeast extract, 1 g/liter thioglycolate) with
antibiotics as necessary for maintenance of plasmids. For experiments, overnights cultures were diluted
in BHIS medium (37 g/liter brain heart infusion, 5 g/liter yeast extract). Antibiotics were used at the
following concentrations: thiamphenicol (Tm), 10 g/ml; chloramphenicol (Cm), 10 g/ml; ampicillin
(Amp), 100 g/ml; and kanamycin (Kn), 100 g/ml. Nisin was added at 0.01 to 2.0 g/ml as indicated to
induce expression from the cpr promoter. Strains and plasmids used in this study are described in
Table S1 in the supplemental material.
RNA sequencing. Single colonies of 630Δerm bearing vector or pDccA were inoculated in TY-Tm
medium and grown for 16 h, with 4 independent replicates per strain. Cultures were diluted 1:100 in
5 ml of BHIS-Tm and grown to an optical density at 600 nm (OD600) of 0.2. Nisin was then added to each
culture at a final concentration of 1 g/ml. Cultures were then grown to an OD600 of 1.0. Cells were
collected by centrifugation at 3,000  g for 10 min. Supernatants were removed, and RNA was extracted
using TriSure (Bioline) and chloroform as described previously (29, 55). RNA was precipitated with 100%
isopropanol and centrifugation at 13,000  g for 10 min at 4°C. Supernatants were removed, and RNA
pellets were washed with cold 70% ethanol and subjected to centrifugation at 13,000  g for 10 min at
4°C. Air-dried RNA pellets were suspended in 50 l of nuclease-free water. RNA was treated with Turbo
DNA-free (Ambion) to remove DNA, and RNA integrity was checked using a Bioanalyzer assay. All RNA
samples had RNA integrity numbers greater than 8. rRNA was depleted using a Ribo Zero (bacteria) rRNA
removal kit (Illumina). Libraries were prepared using the TruSeq Ribo Zero Gold kit (Illumina). Samples
were pooled for single-end sequencing on a Hi-Seq 2500 sequencer (Illumina). A combined 46.9 million
(46.9M) 50-nt reads were obtained for vector control samples, and 63.9M 50-nt reads for pDccA samples.
Base calling and demultiplexing of the data were done using Illumina bcl2fastq v.2.17.0.
RNA sequencing analysis was performed using CLC Genomic Workbench version 9.0 (Qiagen).
Transcripts were mapped to the C. difficile 630 genome (AM180355.1), on which annotations for the
c-di-GMP riboswitches were manually added based on the predictions by Sudarsan et al. and Lee et al.
(20, 21). Reads were mapped to the reference genome with the software’s default scoring penalties for
mismatch, deletion, and insertion differences from the reference genome. Transcript reads for each gene
were normalized to the total number of reads and gene length (expressed as reads per kilobase of
transcript, per million mapped reads [RPKM]) before calculating the fold change. Fold decreases are
expressed as negative numbers. Genes were considered to be regulated by c-di-GMP if the fold change
between the means of the pDccA- and vector-bearing strains was greater than 2 and P  0.05 following
Bonferroni correction for multiple comparisons.
qRT-PCR. Cultures of C. difficile 630Δerm bearing vector, pDccA, or pDccAmut were grown as above
but in a 25-ml volume of BHIS to allow splitting of the cultures for c-di-GMP quantification (see below)
and quantitative reverse transcription-PCR (qRT-PCR). Cultures were grown with a range of nisin
concentrations to achieve a range of dccA expression and intracellular c-di-GMP levels (29). For the
vector and pDccAmut control strains, two nisin concentrations, 0 g/ml and 1 g/ml, were used. For
the pDccA strain, 7 concentrations were used: 0, 0.01, 0.1, 0.25, 0.5, 1.0, and 2.0 g/ml. The cultures
were grown to exponential phase (OD600 of 1.0), and 3-ml samples were collected for qRT-PCR.
Following RNA purification as above, cDNA was synthesized using the High Capacity cDNA Reverse
Transcription kit (Applied Biosystems). A total of 10 ng of cDNA template was used in each qRT-PCR
with SensiMix SYBR Green (Bioline). Primers, designated as gene-qF and qR for the forward and
reverse primers, respectively, were used at a final concentration of 300 nM. All PCR primers were
designed to yield comparably sized products from the first 500 bp (or less) of the gene, and all sets
were determined to have 95% amplification efficiency. The data were analyzed using the 2ΔΔCT
method, with rpoC as a reference gene and normalization to the stated reference condition or strain
(29, 55, 67).
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Quantification of intracellular c-di-GMP. The remaining 22 ml of the above cultures was collected
as matched samples for c-di-GMP quantification. Serial dilutions were plated in BHIS agar for enumer-
ation of CFU. Cells were then collected by centrifugation at 2,500  g for 10 min. Supernatants were
removed, and cell pellets were suspended in 1 ml PBS and transferred to a 1.5 -ml microcentrifuge tube.
Samples were centrifuged at 10,000  g, and supernatants were removed. Pellets were suspended in
200 l of extraction buffer (40% acetonitrile, 40% methanol, 0.1 N formic acid) and placed at 20°C for
30 min. Samples were centrifuged at 12,000  g for 5 min at 4°C, and 200-l aliquots of the supernatant
were transferred to clean tubes and immediately neutralized by adding 8 l of 15% (wt/vol) NH4HCO3.
The c-di-GMP concentration in these samples was determined by UPLC/MS as described previously (55).
Intracellular c-di-GMP was calculated by normalizing measured c-di-GMP concentrations to the total
cytoplasmic volume extracted, estimated using enumerated CFU in each sample, as described previously
(29, 55).
Construction of plasmids for expression of genes encoding cell wall proteins. Primers used for
strain construction are listed in Table S2 in the supplemental material. The tet promoter from pRPF185
(68) was amplified by PCR using primers ATc_F  ATc_R. The PCR product was digested with the
restriction enzymes EcoRI and SacI, ligated into similarly digested pMC123, and transformed into
Escherichia coli DH5. This plasmid (pRT1648) served as the vector control. The cell wall protein genes
were amplified from 630Δerm genomic DNA using primers named according to LOCUSTAG_F and
LOCUSTAG_R for the forward and reverse primers, respectively. The PCR products were ligated into
pRT1648 using the SacI and BamHI restriction sites. These plasmids were conjugated into C. difficile
630Δerm as described previously (29).
Biofilm assay. Biofilm formation was assayed as described previously (31, 32, 55). Briefly, biofilms
were grown in 1 ml modified BHIS (BHIS  1% glucose  50 mM sodium phosphate, pH 7.5) containing
10 g/ml thiamphenicol and 20 ng/ml ATc. Bacteria were grown statically for 24 h at 37°C anaerobically.
After 24 h, biofilm formation was measured using crystal violet staining.
Motility assay. Swimming motility was assayed as described previously (29, 44). Briefly, 2 l of
overnight cultures were inoculated into 0.5 BHIS-0.3% agar medium supplemented with Tm10 to
maintain plasmids and incubated at 37°C. Diameters of motility were measured after 24 h.
Construction of reporter fusions. Promoter regions upstream of each riboswitch were amplified
from 630Δerm genomic DNA using primers named cdiX-XpromF and cdiX-XpromR (Table S2). For
example, for Cdi-1-1, the promoter was amplified using Cdi1-1promF and Cdi1-1promR. Amplified
promoter regions were cloned into SalI- and SphI-digested pRT1346 (pSMB47::phoZ) (44) and then
transformed into E. coli DH5 cells. Correct clones were identified by PCR and sequencing. Purified
plasmids were transformed into Bacillus subtilis BS49, which contains Tn916 (69, 70). Single colonies of
the BS49 strains containing the reporter fusions were used in conjugations with C. difficile 630Δerm as
described previously (44, 71). This method results in semirandom integration of the reporter fusion on
the C. difficile chromosome. Plasmids pMC-Pcpr (vector) and pDccA were introduced into these C. difficile
strains via conjugation with E. coli HB101(pRK24) donors (29).
Alkaline phosphatase assay. Single colonies of reporter fusion strains bearing vector or pDccA were
inoculated into 2 ml TY-Tm and grown for 16 h. Cultures were diluted 1:100 in 3 ml of BHIS-Tm with
various concentrations of nisin (0, 0.01, 0.1, 0.25, 0.5, 1.0, and 2.0 g/ml). At mid-exponential phase
(OD600 of 1.0), 1 ml of each culture was collected, and cells were collected by centrifugation for 1 min
at 12,000  g. Supernatants were discarded, and bacteria were stored at 20°C. Alkaline phosphatase
activity was measured as described by Edwards et al. (41).
Accession number(s). The raw and processed data files are accessible through NCBI Geo (accession
number GSE120198).
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